Autologous transplant, also known as single autologous, is the standard for most diseases. Autologous transplants are the most frequently performed and involve patients receiving their own stem cells. The procedure is used for patients with multiple myeloma, lymphoma, amyloidosis and testicular cancer.
Based on a patient’s response to the disease, the physician determines the best time to collect the stem cells. Prior to transplant, stem cells are mobilized, collected and frozen. Specifically, they are mobilized through growth factor called granulocyte colony-stimulating factor (G-CSF) or a combination of chemotherapy and G-CSF. Upon mobilization, the stem cells are collected using an apheresis machine, and then processed and cryopreserved until the patient is ready for the transplant procedure.
Last Review Date: July 19, 2013
Online Editor(s): Shannon Krause